Menetrier's disease (or Menetrier's disease) is a rare but serious disease of the stomach characterized by hypertrophy of the mucous membrane and hyperproduction of gastritis. It is a precancerous condition that is associated with the development of metaplasia and dysplasia in the gastric mucosa. Menetrier's disease manifests itself clinically in the form of gastralgia, dyspeptic disorders and weight loss, which may be due to severe disturbances in the absorption of nutrients. This disease requires a comprehensive approach to diagnosis, treatment and monitoring of patients, since early detection and adequate treatment can significantly affect the outcome.
History of the disease and interesting historical facts
Menetrier's disease was first described in 1888 by the physician whose name the disease bears, Georges Menetrier. He identified characteristic changes in the gastric mucosa and noted a link between the disease and mutated epithelium. Throughout the 20th century, various studies have been conducted that have helped to establish the pathogenesis of the disease, but there are still unresolved questions regarding its etiology. In 2005, scientists discovered that a specific virus, the pleurisy-associated lymphoma virus, may contribute to the development of Menetrier's disease.
Epidemiology
According to various epidemiological studies, the incidence of Menetriev's disease ranges from 0.1 to 0.5 cases per 100,000 population per year. This disease is more common in men aged 40 to 60 years. Only isolated cases have been recorded in world practice, which indicates the rarity of this pathological condition.
Genetic predisposition to this disease
Studies show that there is a genetic predisposition to Menetrier disease. In particular, decreased levels of certain genes have been identified, such as TGF-β and Wnt, which are involved in the regulation of cell growth and differentiation. Various mutations in these genes may predispose to the development of the pathology. In addition, the influence of X-linked genes on the development of this disease has been confirmed, although the specific mechanisms remain poorly understood to date.
Risk factors for the development of this disease
Risk factors for developing Menetrier disease include:
- Chronic infections (eg, Helicobacter pylori);
- Smoking;
- Family history of gastric disease;
- Long-term use of nonsteroidal anti-inflammatory drugs;
- Problems with the immune system;
- Chemical exposures (eg pesticides);
Studying these factors helps in developing measures to prevent the disease.
Diagnosis of this disease
Diagnosis of Menetria's disease includes several stages:
- Main symptoms: Pain in the upper abdomen, chronic gastritis, heartburn, vomiting, loss of appetite and weight loss.
- Laboratory tests: Complete blood count, tests for anemia and Helicobacter pylori infection.
- Radiological examinations: Ultrasound examination of abdominal organs, radiography using contrast agent.
- Other types of diagnostics: Endoscopy and biopsy to confirm the diagnosis based on histological examination. This is one of the most important diagnostic methods.
- Differential diagnosis: It is necessary to exclude other diseases of the gastric system, such as peptic ulcer, stomach cancer and osteodystrophy.
Treatment
Treatment of Menetria's disease is complex and may include:
- General treatment: Correction of diet and lifestyle, including giving up alcohol and smoking.
- Pharmacological treatment: The use of anti-Helicobacter therapy, which suppresses the secretory activity of gastric mucosa cells, and drugs to reduce acidity.
- Surgical treatment: Wart gastrectomy in cases of severe forms of the disease complicated by loss of nutrients and development of carcinoma.
- Other types of treatment: Physiotherapeutic methods, use of immunostimulants to increase the body's resistance.
List of medications used to treat this disease
The main drugs recommended for the treatment of Menetria disease include:
- Proton pump inhibitors (omeprazole, lansoprazole);
- Antibiotics (omeprazole in combination with amoxicillin and clarithromycin for the treatment of H. pylori);
- Antacids to reduce gastritis;
- Drugs that regulate gastric motility (metoclopramide);
- Immunomodulatory drugs.
Disease monitoring
Monitoring of the condition in Menetria disease includes:
- Regular check-ups (endoscopy and histological examination);
- Assessment of nutritional status and dietary adjustments as needed;
- General health assessment and monitoring of weight gain;
- Forecast: the disease requires long-term observation, as there is a risk of malignancy;
- Complications: Carcinomas, anemia, and nutritional deficiencies may occur.
Age-related features of the disease
Menetriev's disease has different manifestations depending on the age group of patients:
- In young people, the disease often manifests itself as gastritis with predominant dyspeptic symptoms.
- In middle-aged patients, pronounced changes in the mucous membrane are observed, and weight loss is often observed.
- In elderly patients, the risk of acute complications increases significantly due to comorbidities and a worse prognosis.
Questions and Answers
- What is Menetrier's disease?
This is a rare disease of the stomach, characterized by hypertrophy of the mucous membrane and precancerous changes. - What are the main symptoms of the disease?
Symptoms include abdominal pain, loss of appetite, vomiting, indigestion and weight loss. - How is the diagnosis carried out?
Diagnosis includes endoscopy, biopsy, radiography, and laboratory tests for H. pylori infection. - What treatment is indicated?
Treatment may include drug therapy, dietary nutrition, and surgery in severe cases. - Is there a predisposition to the disease?
Yes, genetic mutations and risk factors such as infections and lifestyle can contribute to the development of the disease.
